| 000 | 04879nam a2200421 i 4500 | ||
|---|---|---|---|
| 999 |
_c394967 _d394967 |
||
| 001 | 394967 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230110150015.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 221224s2022 sz a o |||| 0|eng d | ||
| 020 | _a9783031154782 | ||
| 024 | 7 |
_a10.1007/978-3-031-15478-2 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRA644.C67 _b2022 EB |
|
| 245 | 0 | 0 |
_aCardiovascular Complications of COVID-19 : _bAcute and Long-Term Impacts _cedited by Maciej Banach |
| 250 | _a1st edition 2022 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2022 |
|
| 300 |
_a1 recurso en línea (XV, 437 páginas) _b59 ilustraciones, 49 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aContemporary Cardiology _x2196-8977 |
|
| 505 | 0 | _aPart I: Introduction -- Biology of SARS-CoV-2 coronavirus; origin, structure, and variants -- Epidemiology of COVID-19 -- Clinical symptoms and course of COVID-19 -- Risk factors of developing COVID-19 and its severe course -- Prognosis in COVID-19 patients - statistics, risk factors -- Part II: Cardiovascular Implications of the Acute Phase of COVID-19 -- Myocardial injury in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Acute coronary syndrome - destabilization of atherosclerotic plaque in COVID-19 (epidemiology, influence on prognosis, pathogen-esis and treatment) -- Acute Vascular Injury in COVID-19 -- Heart failure and acute circulatory failure in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Cardiomyopathy in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Arrhythmias in COVID-19 -- Thromboembolic events in COVID-19 -- Stroke in COVID-19 -- Pulmonary embolism after COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) -- Interaction of anti-COVID-19 drugs with cardiovascular therapy -- Part III: Influence of the Treatment of Cardiovascular Diseases on the Course of COVID-19 -- Beyond the vaccines-Bioactive lipids in COVID-19 -- Statins and COVID-19 (mechanism of action, effect on prognosis) -- Covid-19 And Antihypertensive Treatment -- Colchicine in COVID-19 (mechanism of action, effect on prognosis) -- Antiplatelet drugs in COVID-19: mechanism of action and effect on prognosis -- Antidiabetic drugs in COVID-19 -- Part IV: Cardiovascular Complications of Long-COVID-19 -- Long COVID-19 - Definition, Epidemiology, and Clinical Implications -- Cardiovascular complications of long COVID-19 - prevalence, diagnosis and risk factors -- Cardiovascular complications of Long-COVID - management -- Part V The impact of COVID-19 pandemic on the e-services and digital tools development in medicine -- The impact of the COVID-19 pandemic on e-services and digital tools development in medicine. | |
| 520 | _aThis book is the first comprehensive approach on COVID-19 cardiac complications, both during the acute phase as well as in the long-COVID period. It provides an up-to-date and highly illustrated summary of the biology of SARS-CoV-2, the course of COVID-19, risk factors that worsen the disease in COVID-19 patients, clinical features of COVID-19 patients, COVID-19 cardiological complications, treatment, and prevention methods, and long-term cardiological aspects of COVID-19. Chapters provide the reader with a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease. In addition, this volume discusses the clinical implications and therapeutic goals in patients with COVID-19 and cardiac complications, as well as possible therapeutic options. It also offers clear recommendations on how to manage (both non- and pharmacologically) to avoid the increased number of COVID-19 related deaths due to CVD and its risk factors. Cardiovascular Complications of COVID-19 will be the primary resource for physicians, residents, fellows, and nursed and medical students in the fields of cardiology and COVID-19/infectious diseases as well as healthcare providers that initiate preventive activities and dedicated programs. | ||
| 988 | _aSpringer_Medicine_2022 | ||
| 650 | 7 |
_2embne _9683668 _aCOVID-19 |
|
| 650 | 7 |
_2embne _9169062 _aAparato circulatorio _xEnfermedades |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783031154775 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031154799 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783031154805 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-15478-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b01/2023 _dz _eb _zSI |
||